GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs)

International Journal of Biochemistry and Cell Biology

Volumn 46, Issue 1, 2014, Pages 56-67

  Pupo, Marco ^a   Pisano, Assunta ^a   Abonante, Sergio ^b   Maggiolini, Marcello ^a   Musti, Anna Maria ^a,c  

^a UNIVERSITY OF CALABRIA   (Italy)

^b Regional Hospital   (Italy)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Breast cancer; Cancer associated fibroblasts; Estrogens signaling; GPER; Notch signaling

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; G PROTEIN COUPLED RECEPTOR; GAMMA SECRETASE; JAGGED1; MESSENGER RNA; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; BREAST CANCER; CANCER ASSOCIATED FIBROBLAST; CANCER CELL CULTURE; CELL ADHESION; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; GENE EXPRESSION; INTRACELLULAR MEMBRANE; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSACTIVATION; UPREGULATION;

BREAST CANCER; CANCER-ASSOCIATED FIBROBLASTS; ESTROGENS SIGNALING; GPER; NOTCH SIGNALING;

BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLOPENTANES; ESTRADIOL; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; QUINOLINES; RECEPTOR CROSS-TALK; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84889786238     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.11.011     Document Type: Article

References (53)

1. L. Albanito, R. Lappano, A. Madeo, A. Chimento, E.R. Prossnitz, and A.R. Cappello G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells Environ Health Perspect 116 2008 1648 1655
2. L. Albanito, A. Madeo, R. Lappano, A. Vivacqua, V. Rago, and A. Carpino G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells Cancer Res 67 2007 1859 1866
3. L. Albanito, D. Sisci, S. Aquila, E. Brunelli, A. Vivacqua, and A. Madeo Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells Endocrinology 149 2008 3799 3808
4. H. Al-Hussaini, D. Subramanyam, M. Reedijk, and S.S. Sridhar Notch signaling pathway as a therapeutic target in breast cancer Mol Cancer Ther 10 2011 9 15
5. P. Ascenzi, A. Bocedi, and M. Marino Structure-function relationship of estrogen receptor alpha and beta: impact on human health Mol Aspects Med 27 2006 299 402
6. V. Bartella, P. De Marco, R. Malaguarnera, A. Belfiore, and M. Maggiolini New advances on the functional cross-talk between insulin-like growth factor-I and estrogen signaling in cancer Cell Signal 24 2012 1515 1521
7. C.G. Bologa, C.M. Revankar, S.M. Young, B.S. Edwards, J.B. Arterburn, and A.S. Kiselyov Virtual and biomolecular screening converge on a selective agonist for GPR30 Nat Chem Biol 2 2006 207 212
8. J. Chen, N. Imanaka, J. Chen, and J.D. Griffin Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion Br J Cancer 102 2010 351 360
9. A. Chimento, R. Sirianni, I. Casaburi, C. Ruggiero, M. Maggiolini, and S. Andò 17β-Estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line Mol Cell Endocrinol 355 2012 49 59
10. P. De Marco, V. Bartella, A. Vivacqua, R. Lappano, M.F. Santolla, and A. Morcavallo Insulin-like growth factor-I regulates GPER expression and function in cancer cells Oncogene 32 2013 678 688
11. M.K. Dennis, A.S. Field, R. Burai, C. Ramesh, W.K. Petrie, and C.G. Bologa Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity J Steroid Biochem Mol Biol 127 2011 358 366
12. Y. Endo, K. Deonauth, P. Prahalad, B. Hoxter, Y. Zhu, and S.W. Byers Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells PLoS ONE 3 2008 e2714
13. E. Filice, A.G. Recchia, D. Pellegrino, T. Angelone, M. Maggiolini, and M.C. Cerra A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat J Physiol Pharmacol 60 2009 3 10
14. J. Grego-Bessa, J. Díez, L. Timmerman, and J.L. de la Pompa Notch and epithelial-mesenchyme transition in development and tumor progression: another turn of the screw Cell Cycle 3 2004 718 721
15. S. Guo, M. Liu, and R.R. Gonzalez-Perez Role of Notch and its oncogenic signaling crosstalk in breast cancer Biochim Biophys Acta 15 2011 197 213
16. S. Hiraguri, T. Godfrey, H. Nakamura, J. Graff, C. Collins, and L. Shayesteh Mechanisms of inactivation of E-cadherin in breast cancer cell lines Cancer Res 58 1998 1972 1977
17. T. Iso, L. Kedes, and Y. Hamamori HES and HERP families: multiple effectors of the Notch signaling pathway J Cell Physiol 194 2003 237 255
18. R. Kalluri, and M. Zeisberg Fibroblasts in cancer Nat Rev Cancer 6 2006 392 401
19. R. Kopan, and M.X. Ilagan The canonical Notch signaling pathway: unfolding the activation mechanism Cell 137 2009 216 233
20. R. Lappano, P. De Marco, E.M. De Francesco, A. Chimento, V. Pezzi, and M. Maggiolini Cross-talk between GPER and growth factor signaling J Steroid Biochem Mol Biol 2013 10.1016/j.jsbmb.2013.03.005
21. R. Lappano, A.G. Recchia, E.M. De Francesco, T. Angelone, M.C. Cerra, and D. Picard The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes PLoS ONE 6 2011 e16631
22. R. Lappano, C. Rosano, P. De Marco, E.M. De Francesco, V. Pezzi, and M. Maggiolini Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells Mol Cell Endocrinol 320 2010 162 170
23. R. Lappano, C. Rosano, M.F. Santolla, M. Pupo, E.M. De Francesco, and P. De Marco Two novel GPER agonists induce gene expression changes and growth effects in cancer cells Curr Cancer Drug Targets 12 2012 531 542
24. R. Lappano, M.F. Santolla, M. Pupo, M.S. Sinicropi, A. Caruso, and C. Rosano MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells Breast Cancer Res 14 2012 R12
25. J. Liang, and Y. Shang Estrogen and cancer Annu Rev Physiol 75 2013 225 240
26. A. Madeo, and M. Maggiolini Nuclear alternate estrogen receptor GPR30 mediates 17βestradiol-induced gene expression and migration in breast cancer-associated fibroblasts Cancer Res 70 2010 6036 6046
27. A. Madeo, M. Vinciguerra, R. Lappano, M. Galgani, A. Gasperi-Campani, and M. Maggiolini c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells Oncogene 29 2010 978 991
28. M. Maggiolini, O. Donzé, and D. Picard A non-radioactive method for inexpensive quantitative RT-PCR Biol Chem 380 1999 695 697
29. M. Maggiolini, and D. Picard The unfolding stories of GPR30, a new membrane-bound estrogen receptor J Endocrinol 204 2010 105 114
30. M. Maggiolini, A. Vivacqua, G. Fasanella, A.G. Recchia, D. Sisci, and V. Pezzi The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells J Biol Chem 279 2004 27008 27016
31. Y. Matsuno, A.L. Coelho, G. Jarai, J. Westwick, and C.M. Hogaboam Notch signaling mediates TGF-β1-induced epithelial-mesenchymal transition through the induction of Snai1 Int J Biochem Cell Biol 44 2012 776 789
32. L. Miele Notch signaling Clin Cancer Res 12 2006 1074 1079
33. C. Osipo, P. Patel, P. Rizzo, A.G. Clementz, L. Hao, and T.E. Golde ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor Oncogene 27 2008 5019 5032
34. D.P. Pandey, R. Lappano, L. Albanito, A. Madeo, M. Maggiolini, and D. Picard Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF EMBO J 28 2009 523 532
35. M.L. Panno, M. Salerno, V. Pezzi, D. Sisci, M. Maggiolini, and L. Mauro Effect of oestradiol and insulin on the proliferative pattern and on oestrogen and progesterone receptor contents in MCF-7 cells J Cancer Res Clin Oncol 122 1996 745 749
36. M. Pupo, A. Pisano, R. Lappano, M.F. Santolla, E.M. De Francesco, and S. Abonante Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts Environ Health Perspect 120 2012 1177 1182
37. M. Pupo, A. Vivacqua, I. Perrotta, A. Pisano, S. Aquila, and S. Abonante The nuclear localization signal is required for nuclear GPER translocation and function in breast Cancer-Associated Fibroblasts (CAFs) Mol Cell Endocrinol 376 2013 23 32
38. A.G. Recchia, E.M. De Francesco, A. Vivacqua, D. Sisci, M.L. Panno, and S. Andò The G protein-coupled receptor 30 is up-regulated by hypoxia inducible factor-1α(HIF-1α) in breast cancer cells and cardiomyocytes J Biol Chem 286 2011 10773 10782
39. M. Reedijk, S. Odorcic, L. Chang, H. Zhang, N. Miller, and D.R. McCready High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival Cancer Res 65 2005 8530 8537
40. C.M. Revankar, D.F. Cimino, L.A. Sklar, J.B. Arterburn, and E.R. Prossnitz A transmembrane intracellular estrogen receptor mediates rapid cell signalling Science 307 2005 1625 1630
41. P. Rizzo, H. Miao, G. D'Souza, C. Osipo, L.L. Song, and J. Yun Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches Cancer Res 68 2008 5226 5235
42. P. Rizzo, C. Osipo, K. Foreman, T. Golde, B. Osborne, and L. Miele Rational targeting of Notch signaling in cancer Oncogene 27 2008 5124 5131
43. C. Rosano, R. Lappano, M.F. Santolla, M. Ponassi, A. Donadini, and M. Maggiolini Recent advances in the rationale design of GPER ligands Curr Med Chem 19 2012 6199 6206
44. M.F. Santolla, R. Lappano, P. De Marco, M. Pupo, A. Vivacqua, and D. Sisci GPER mediates the up-regulation of fatty acid synthase (FASN) induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts (CAFs) J Biol Chem 287 2012 43234 43245
45. J.P. Thiery Epithelial-mesenchymal transitions in tumour progression Nat Rev Cancer 2 2002 442 454
46. P. Thomas, Y. Pang, E.J. Filardo, and J. Dong Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells Endocrinology 146 2005 624 632
47. A. Vivacqua, D. Bonofiglio, L. Albanito, A. Madeo, V. Rago, and A. Carpino 17β-Estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein coupled-receptor GPR30 Mol Pharmacol 70 2006 1414 1423
48. A. Vivacqua, D. Bonofiglio, A.G. Recchia, A.M. Musti, D. Picard, and S. Andò The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17β-estradiol and hydroxytamoxifen in endometrial cancer cells Mol Endocrinol 20 2006 631 646
49. A. Vivacqua, R. Lappano, P. De Marco, D. Sisci, S. Aquila, and F. De Amicis G protein-coupled receptor 30 expression is up-regulated by EGF and TGFα in estrogen receptor alpha-positive cancer cells Mol Endocrinol 23 2009 1815 1826
50. A. Vivacqua, E. Romeo, P. De Marco, E.M. De Francesco, S. Abonante, and M. Maggiolini GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells Breast Cancer Res Treat 133 2012 1025 1035
51. Z. Wang, Y. Li, D. Kong, and F.H. Sarkar The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness Curr Drug Targets 11 2010 745 751
52. L. Wu, and J.D. Griffin Modulation of Notch signaling by mastermind-like (MAML) transcriptional co-activators and their involvement in tumorigenesis Semin Cancer Biol 14 2004 348 356
53. L. Yin, O.C. Velazquez, and Z.J. Liu Notch signaling: emerging molecular targets for cancer therapy Biochem Pharmacol 80 2010 690 701